அமெரிக்கன் ஜர்னல் ஆஃப் மருந்து விநியோகம் மற்றும் சிகிச்சை திறந்த அணுகல்

சுருக்கம்

Safe design approach for toxicity of silica nanocapsule

Kaczerewska Olga

Mesoporous silica nanocapsules are a well-known and leading nanocontainers’ system applied in several fields (corrosion protection, antifouling, drug delivery). However, it has been already reported that the monomeric cationic surfactant hexadecyltrimethylammonium bromide (CTAB), used as a template in the synthesis of these nanocapsules, should be replaced because of being a source of nanocapsules’ toxicity. In this work we investigate the replacement of CTAB with dimeric surfactants, known as gemini surfactants. Works already available in the literature show that gemini surfactants tend to exhibit lower toxicity to fresh water and marine species than their conventional analogues. Therefore, this study can be envisaged as a safe-by-design approach to silica nanocapsules synthesis by replacing a commercial surfactant (CTAB) with a gemini surfactant (QSB2-12). Nanocapsules prapred using both surfactants were fully characterized by different techniques (BET, FTIR, DLS, TGA, SEM), while the short-term exposure effect was evaluated towards four marine species (the green microalgae Nannochloropsis gaditana and Tetraselmis chuii, the diatom Phaeodactylum tricornutum, and the microcrustacean Artemia salina).  

A nanocapsule is a nanoscale shell produced using a nontoxic polymer. They are vesicular frameworks made of a polymeric film which epitomizes an inward fluid center at the nanoscale. Nanocapsules have numerous utilizations, including promising clinical applications for tranquilize conveyance, food upgrade, nutraceuticals, and for self-recuperating materials. The advantages of exemplification techniques are for assurance of these substances to ensure in the unfavorable condition, for controlled discharge, and for exactness targeting. Nanocapsules can conceivably be utilized as MRI-guided nanorobots or nanobots, despite the fact that difficulties remain. The ordinary size of the nanocapsule utilized for different applications ranges from 10-1000 nm. Notwithstanding, contingent upon the planning and utilization of the nanocapsule, the size will be more specific.  

Nanocapsule structure comprises of nanovesicular framework that is shaped in a center shell game plan. The shell of an ordinary nanocapsule is made of a polymeric layer or covering. The kind of polymers utilized is of biodegradable polyester, as nanocapsules are frequently utilized in natural frameworks. Poly-e-caprolactone (PCL), poly(lactide) (PLA), and poly(lactide-co-glicolide) (PLGA) are commonplace polymers utilized in nanocapsule formation. Other polymers incorporate thiolated poly(methacrylic corrosive) and poly(N-vinyl Pyrrolidone). As manufactured polymers have demonstrated to be increasingly unadulterated and reproducible when thought about normally happening polymers, they are frequently favored for the development nanocapsules. Be that as it may, some regular happening polymers, for example, chitosan, gelatin, sodium alginate, and egg whites are utilized in some medication conveying nanocapsules. Other nanocapsule shells incorporate liposomes, alongside polysaccharides and saccharides. Polysaccharides and saccharides are utilized due to their non-poisonousness and biodegradability. They are appealing to use as they take after organic membranes.   The center of a nanocapsule is made out of an oil surfactant that is explicitly chosen to facilitate with the chose tranquilize inside the polymeric layer. The particular oil utilized must be profoundly solvent with the medication, and non-harmful when utilized in an organic domain. The oil-tranquilize emulsion must have low dissolvability with the polymer film to guarantee that the medication will be conveyed all through the framework appropriately and be discharged at the best possible time and area. At the point when the correct emulsion is gotten, the medication ought to be consistently scattered all through the whole inner depression of the polymeric film. 

The exemplification technique relies upon the necessities for some random medication or substance. These procedures rely upon the physiochemical properties of the center material, the divider material, and the required size. The most well-known approaches to create nanocapsules are nanoprecipitation, emulsion-dispersion, and dissolvable vanishing.   In the nanoprecipitation technique, additionally named dissolvable dislodging strategy, nanocapsules are shaped by making a colloidal suspension between two separate stages. The natural stage comprises of an answer and a blend of natural solvents. The watery stage comprises of a blend of non-solvents that frames a surface film. The natural stage is gradually infused in the fluid stage which at that point is disturbed to shape the colloidal suspension. When the colloidal suspension is shaped it will be unsettled until nanocapsules start to frame. The size and state of the nanocapsule rely upon the pace of infusion alongside the pace of agitation.   Another regular method to get ready nanocapsules is the emulsion dispersion technique. This technique comprises of three stages: natural, fluid, and weakening stage. In this strategy the natural stage is added to the watery stage under states of high unsettling which structure an emulsion. During this procedure water is added to the emulsion which makes the dissolvable diffuse. The consequence of this emulsion-dissemination is nanocapsule formation. 

 Dissolvable vanishing is another compelling technique to get ready nanocapsules. In this procedure, single or twofold emulsions are shaped from solvents and are utilized to figure a nanoparticle suspension. Rapid homogenization or ultrasonication is utilized to shape little molecule size in the nanoparticle suspension. When the suspension is steady, the solvents are vanished utilizing either nonstop attractive mixing at room temperature, or by lessening the encompassing pressure.